{
  "paper_metadata": {
    "pmid": "27907908",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information and penetrance data from a study on Taiwanese patients with ovarian cancer."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.779_780del",
      "protein_notation": "p.D1451fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Taiwanese, female",
        "phenotype": "serous ovarian carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "serous ovarian carcinoma",
          "evidence_sentence": "One patient carried both a BRCA1 germline mutation and a BRCA2 somatic mutation."
        }
      ],
      "functional_data": {
        "summary": "The variant is a frameshift mutation leading to a premature stop codon.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant was identified as a somatic mutation.",
      "key_quotes": [
        "Five novel frameshift mutations were identified, including four somatic variants (BRCA1 p.S242fs, BRCA1 p.F989fs, BRCA1 p.G1738fs, and BRCA2 p.D1451fs) and a germline variant (BRCA2 p.E260fs)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.779_780del",
      "protein_notation": "p.E260fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Taiwanese, female",
        "phenotype": "serous ovarian carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "serous ovarian carcinoma",
          "evidence_sentence": "One patient carried both a BRCA1 germline mutation and a BRCA2 somatic mutation."
        }
      ],
      "functional_data": {
        "summary": "The variant is a frameshift mutation leading to a premature stop codon.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant was identified as a germline mutation.",
      "key_quotes": [
        "Five novel frameshift mutations were identified, including four somatic variants (BRCA1 p.S242fs, BRCA1 p.F989fs, BRCA1 p.G1738fs, and BRCA2 p.D1451fs) and a germline variant (BRCA2 p.E260fs)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5826C>T",
      "protein_notation": "p.S1946P",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 2,
        "demographics": "Taiwanese, female",
        "phenotype": "one with clear cell carcinoma and the other with serous carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Sister_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "clear cell carcinoma",
          "evidence_sentence": "The recurrent BRCA2 VUS p.S1946P\u2014deemed to be pathogenic owing to its occurrence in two sisters with ovarian cancer."
        },
        {
          "individual_id": "Sister_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "serous carcinoma",
          "evidence_sentence": "The recurrent BRCA2 VUS p.S1946P\u2014deemed to be pathogenic owing to its occurrence in two sisters with ovarian cancer."
        }
      ],
      "functional_data": {
        "summary": "The variant is a missense mutation located nearby the BRC motif, which is essential for BRCA2-mediated recombination repair.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in family.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is rare in healthy subjects of the Taiwanese population.",
      "key_quotes": [
        "The recurrent BRCA2 VUS p.S1946P\u2014deemed to be pathogenic owing to its occurrence in two sisters with ovarian cancer."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Summary of pathogenic BRCA1/2 variants identified in the study.",
      "variants_extracted": 5
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}